4 juillet

Nature Reviews Nephrology http://www.nature.com/ncpneph/

• 00:00
  Application of spatial-omics to the classification of kidney biopsy samples in transplantation - Paola Tasca, Bernard M. van den Berg, Ton J. Rabelink, Gangqi Wang, Bram Heijs, Cees van Kooten, Aiko P. J. de Vries, Jesper Kers Nature Reviews Nephrology
  Nature Reviews Nephrology, Published online: 04 July 2024; doi:10.1038/s41581-024-00861-xTechnological advances continue to enhance the clinical value of kidney biopsies. Here, the authors consider the potential of using spatial-omics in transplantation, including the use of mass spectrometry (…) (Nature Reviews Nephrology, Published online: 2024-07-04; | doi:10.1038/s41581-024-00861-x)

3 juillet

Nature Reviews Nephrology http://www.nature.com/ncpneph/

• 00:00
  The role of antibody glycosylation in autoimmune and alloimmune kidney diseases - Anaïs Beyze, Christian Larroque, Moglie Le Quintrec Nature Reviews Nephrology
  Nature Reviews Nephrology, Published online: 03 July 2024; doi:10.1038/s41581-024-00850-0Here, the authors review the impact of IgG glycosylation in kidney diseases, particularly autoimmune diseases and antibody-mediated rejection. They also discuss the signalling pathways that govern antibody (…) (Nature Reviews Nephrology, Published online: 2024-07-03; | doi:10.1038/s41581-024-00850-0)

2 juillet

Nature Reviews Nephrology http://www.nature.com/ncpneph/

• 00:00
  Regulation of kidney fibrosis by ILC3s via a gut–kidney axis - Susan J. Allison Nature Reviews Nephrology
  Nature Reviews Nephrology, Published online: 02 July 2024; doi:10.1038/s41581-024-00867-5Regulation of kidney fibrosis by ILC3s via a gut–kidney axis (Nature Reviews Nephrology, Published online: 2024-07-02; | doi:10.1038/s41581-024-00867-5)
• 00:00
  A pre-specified analysis of the SELECT trial suggests a kidney benefit of semaglutide in patients without diabetes - Ellen F. Carney Nature Reviews Nephrology
  Nature Reviews Nephrology, Published online: 02 July 2024; doi:10.1038/s41581-024-00865-7A pre-specified analysis of the SELECT trial suggests a kidney benefit of semaglutide in patients without diabetes (Nature Reviews Nephrology, Published online: 2024-07-02; | doi:10.1038/s41581-024-00865-7)
• 00:00
  Avenciguat reduces albuminuria in patients with chronic kidney disease - Ellen F. Carney Nature Reviews Nephrology
  Nature Reviews Nephrology, Published online: 02 July 2024; doi:10.1038/s41581-024-00866-6Avenciguat reduces albuminuria in patients with chronic kidney disease (Nature Reviews Nephrology, Published online: 2024-07-02; | doi:10.1038/s41581-024-00866-6)